Remove special-series
article thumbnail

Virtual SUD clinic Pelago clinches $58M to expand offerings for payers, employers

Fierce Healthcare

Pelago, a virtual substance use disorder (SUD) clinic working with payers and employers, has clinched $58 million in a series C round. Pelago offers integrated SUD management for employers and payers, with specialized treatment for tobacco, alcohol and opioid use disorders.

article thumbnail

Vita Health Secures $22.5M to Combat Suicide and Mental Health Crisis Nationwide

HIT Consultant

Series A funding round. Vita Health stands out as the only telehealth provider specializing in suicide care, while also offering teletherapy and psychiatry services for various behavioral health conditions. The funding will support the rapid expansion of life-saving services targeting youth and adults nationwide.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brightside Health Secures $33M to Expand Access to Mental Healthcare

HIT Consultant

What You Should Know: – Brightside Health , a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32. Their evidence-based approach combines precision psychiatry, clinically proven therapy, and a specialized Crisis Care program to deliver comprehensive mental healthcare.

article thumbnail

Pelago Secures $58M to Expand Substance Use Management as an Employee Benefit

HIT Consultant

Research indicates that in non-specialized substance use disorder (SUD) treatment environments, up to 89% of adults with SUDs may remain undetected, leading to treatment delays, relapses, and increased expenses. What You Should Know: Pelago the leading digital clinic partner to U.S.

article thumbnail

Cleveland Clinic Abu Dhabi adopts NASA EquiTest to treat chronic dizziness

Healthcare It News

A special balance test originally used by NASA in its space programmes has been adopted by an Abu Dhabi hospital to help determine the cause of prolonged or recurrent dizziness. “Our mission here is to find the answer to their problem and get them the treatment they need to take their lives back.” ” THE LARGER CONTEXT.

article thumbnail

What are CY 2024 Policy Updates For MIPS Reporting? (Part II)

p3care

[ Note: P3 Care, as a MIPS-qualified registry, presents your series of blogs on MIPS final rule updates for CY 2023. In ‘Part I’ of our blog series, we delineated the rules and parameters for the quality and cost categories. So, this is the ‘ Part II ’ of our CY 2024 MIPS policy changes.]

Medicare 130
article thumbnail

What are the MIPS 2024 Final Scoring Policy Updates? (Part III)

p3care

[ Note: P3 Care, as a MIPS qualified registry, presents your series of blogs on MIPS final rule updates for CY 2023. The scoring for small practices or participants with special status may vary. So, clinicians participating as subgroups must give special attention. So, this is ‘ Part III ’ of our CY 2024 MIPS policy changes.]